Advertisement
Advertisement

NVAX

NVAX logo

Novavax Inc

9.49
USD
Sponsored
-0.70
-6.87%
Jun 05, 16:00 UTC -4
Closed
exchange

Pre-Market

9.57

+0.08
+0.84%

NVAX Earnings Reports

Positive Surprise Ratio

NVAX beat 19 of 42 last estimates.

45%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$52.12M
/
-$0.41
Implied change from Q1 26 (Revenue/ EPS)
-62.64%
/
+583.33%
Implied change from Q2 25 (Revenue/ EPS)
-78.21%
/
-166.13%

Novavax Inc earnings per share and revenue

On May 06, 2026, NVAX reported earnings of -0.06 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 74.46% surprise. Revenue reached 139.51 million, compared to an expected 79.89 million, with a 74.63% difference. The market reacted with a +15.56% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -0.41 USD, with revenue projected to reach 52.12 million USD, implying an increase of 583.33% EPS, and decrease of -62.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, Novavax Inc reported EPS of -$0.06, beating estimates by 74.46%, and revenue of $139.51M, 74.63% above expectations.
The stock price moved up 15.56%, changed from $8.10 before the earnings release to $9.36 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 7 analysts, Novavax Inc is expected to report EPS of -$0.41 and revenue of $52.12M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement